Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/2003
04/24/2003CA2463628A1 Himbacine analogues as thrombin receptor antagonists
04/24/2003CA2463518A1 Carbinols for the treatment of neuropathic dysfunction
04/24/2003CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/24/2003CA2463469A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/24/2003CA2463159A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
04/24/2003CA2463016A1 Composition comprising paracetamol and a bitterness masking component
04/24/2003CA2462442A1 Alkyne matrix metalloproteinase inhibitors
04/24/2003CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
04/24/2003CA2462147A1 Bicyclic oxopyridine and oxopyrimidine derivatives
04/24/2003CA2461758A1 Use of cystathionine
04/24/2003CA2461245A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
04/24/2003CA2461170A1 Peptidyl ketones as inhibitors of dpiv
04/24/2003CA2460685A1 Cyclosporine analogue mixtures and their use as immunomodulating agents
04/24/2003CA2460574A1 Enteric coated tablets comprising mycophenolic acid or mycophenolate salt
04/24/2003CA2453264A1 Novel drug targets for arthritis
04/23/2003EP1304379A2 Humanised antibody against CD18
04/23/2003EP1304378A1 ARL-2 for fertility control
04/23/2003EP1304322A2 Carboxylic acid compound and use thereof
04/23/2003EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
04/23/2003EP1303632A2 Galactomannan oligosaccharides and methods for the production and use thereof
04/23/2003EP1303625A2 Alpha-msh related compounds and methods of use
04/23/2003EP1303610A2 Extracellular matrix protein
04/23/2003EP1303607A2 High affinity soluble interleukin-18 receptor
04/23/2003EP1303596A2 Antisense enzyme inhibitors for improving pharmacokinetics of a drug
04/23/2003EP1303541A1 Gel compositions containing metronidazole
04/23/2003EP1303528A1 Adenosine compound and pharmaceutical composition containing the same
04/23/2003EP1303527A1 Matrix metalloproteinase inhibitors
04/23/2003EP1303520A1 Therapeutic compounds and methods
04/23/2003EP1303517A1 Indoloquinazolinones
04/23/2003EP1303513A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
04/23/2003EP1303512A1 Process for preparing arylacetylaminothiazoles
04/23/2003EP1303508A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents
04/23/2003EP1303506A1 6-heteroarylphenanthridines
04/23/2003EP1303501A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
04/23/2003EP1303496A1 Pyrimidine derivatives
04/23/2003EP1303492A2 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists
04/23/2003EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
04/23/2003EP1303488A1 Piperidine compounds for use as ccr-3 inhibitors
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/23/2003EP1303477A2 1-amino-alkylcyclohexanes as 5-ht3- and neuronal nicotinicreceptor antagonists
04/23/2003EP1303292A1 Chemokine conjugates
04/23/2003EP1303290A1 Small peptides and methods for downregulation of ige
04/23/2003EP1303286A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
04/23/2003EP1303281A1 Methods of treatment
04/23/2003EP1303279A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
04/23/2003EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
04/23/2003EP1303265A2 Use of cox-2 inhibitors for preventing immunodeficiency
04/23/2003EP1303261A2 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
04/23/2003EP1257537A4 Therapeutic morpholino-substituted compounds
04/23/2003EP1250055A4 Immune modulation with death receptor-induced apoptosis
04/23/2003EP1220863B1 Purine derivatives
04/23/2003EP1218378B1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives
04/23/2003EP1146862B1 Pharmaceutical compositions
04/23/2003EP1133483B1 Il-5 inhibiting 6-azauracil derivatives
04/23/2003EP1117681B1 Rho-cocotoxin peptides having selective alpha-1 adrenoceptor activity
04/23/2003EP1114046B1 Interleukin-5 inhibiting 6-azauracil derivatives
04/23/2003EP1107744B1 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia
04/23/2003EP1105109B1 Injectable formulations of nanoparticulate naproxen
04/23/2003EP1045851B1 Substituted porphyrins
04/23/2003EP1045690B1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
04/23/2003EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
04/23/2003EP0993442B1 Hydrazine derivatives
04/23/2003EP0873315B1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
04/23/2003EP0854723B1 Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies as antiinflammatory agents
04/23/2003CN1413249A Human heparanase-related polypeptide and nucleic acid
04/23/2003CN1413215A Process for preparation of pyrazolo pyridazine derivatives
04/23/2003CN1413213A Azaindoles
04/23/2003CN1413211A Substituted 1,3,4-oxadiazoles and method of producing TNF-alpha levels
04/23/2003CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/23/2003CN1413208A Novel derivatives of 3-imino-1,2,-dithioles, method for producing them and pharmaceutical compositions containing the same
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/23/2003CN1413206A Non peptide tachykinin receptor antagonists
04/23/2003CN1413198A Methods and compositions utilizing quianzolinones
04/23/2003CN1413193A Nitrile derivatives as cathepsin K inhibitors
04/23/2003CN1413192A Substituted indole mannich bases
04/23/2003CN1413186A Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha
04/23/2003CN1413185A Substitued 1 and 2 naphthol mannich bases
04/23/2003CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
04/23/2003CN1413118A Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof
04/23/2003CN1413109A Substituted acylhydroxamic acids and method of reducing TNF-alpha levels
04/23/2003CN1413108A 6-methoxy-2-naphthylacetic acid prodrugs composition for curing inflammation
04/23/2003CN1413106A 6-methoxy-2-naphthylacetic acid prodrugs for curing inflammation
04/23/2003CN1413105A Novel method of treatment
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/23/2003CN1411864A High-energy biological vector preparation for expelling cold, promoting blood circulation and removing obatruction in channel and its preparation method
04/23/2003CN1411863A Clematis liquor
04/23/2003CN1411856A Displaying and curing liquor for rheumatism
04/23/2003CN1411851A Chinese adhesive plaster for curing rheumatism and hyperosteogeny
04/23/2003CN1411848A Chinese medicine liquor for clearing and activating channels and collaterals
04/23/2003CN1411836A Carthamus flower medicated liquor
04/23/2003CN1411831A Borneol toad pain-stopping adhesive plaster and its preparation method
04/23/2003CN1411828A Medicine for preventing acute upper respiratory tract infection of children group
04/23/2003CN1411811A 血液循环改善剂 Blood circulation improving agent
04/23/2003CN1411809A Usage and composition of pyridine onium derivative for curing application
04/23/2003CN1411800A Cosmetic composition and method
04/23/2003CN1106394C Dihydrobenzopyran and dihydrobenzopyran compound and their use
04/23/2003CN1106390C Tachykinin receptor antagonist substituted methyl keto-morpholine crystal form
04/23/2003CN1106387C PDEIV inhibiting 2-cyanoiminoimidazole derivatives
1 ... 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 ... 1272